Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials.

The use of prospective consent to perform personalised genetic testing on samples obtained through the routine NBSP represents a novel mechanism for clinical genetic research in the UK and provides a model for further population-based genetic studies in the newborn.